ConductScience.org, home

Trial · NCT03658642

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD

NCT03658642, Not applicable, Completed, Yale University; results first posted 2022-06-28

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD. Trials, record NCT03658642. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03658642

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD
NCT number
NCT03658642
Status
Completed
Phases
Not applicable
Enrollment
5,047 participants, actual
Lead sponsor
Yale University
Conditions
Clinical Decision Support, Buprenorphine, Opioid-use Disorder
Interventions
Clinical Decision Support (CDS)
First posted
2018-09-05
Last updated
2022-06-28
Results first posted
2022-06-28

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCount of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual CareUpon discharge (Up to 1 day)
The primary outcome will be Buprenorphine (BUP) initiation in the Emergency Department (ED), defined as whether or not an eligible patient is administered BUP in the ED and/or prescribed BUP upon discharge from the ED. Although this is not a patient-centered outcome, it is a pragmatic and meaningful surrogate that will serve as a lead indicator of the CDS intervention's effect on engaging more OUD patients in treatment. Medications for Opioid Use Disorder (MOUD)
SecondaryCount of Those With Referral to Follow-up for Ongoing MOUD Treatment (Patient Level)Upon discharge (Up to 1 day)The count of enrolled patients who receive an Medication Assisted Therapy (MAT) appointment. Medications for Opioid Use Disorder (MOUD)
SecondaryRates Receiving a MAT Appointment Who go to the Appointment18 monthsData will be collected in the aggregate for the percentage of patients that attended the referral MAT appointment
SecondaryNumber of Clinicians Providing ED-initiated BUP18 monthsNumber of clinicians providing ED-initiated BUP regardless of CDS
SecondaryNumber of Clinicians Providing Referral of Any Ongoing MOUD Treatment18 monthsNumber of clinicians that refer patients with OUD regardless of CDS
SecondaryNumber of Clinicians Who Have Received Drug Addiction Treatment Act (DATA) of 2000 Training18 monthsNumber of clinicians that obtained DATA waiver

Outcomes6

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYCount of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual CareUpon discharge (Up to 1 day)ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCount of Those With Referral to Follow-up for Ongoing MOUD Treatment (Patient Level)Upon discharge (Up to 1 day)ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYRates Receiving a MAT Appointment Who go to the Appointment18 monthsThese data were not able to be obtained.
SECONDARYNumber of Clinicians Providing ED-initiated BUP18 monthsClinicians participating in the study.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Clinicians Providing Referral of Any Ongoing MOUD Treatment18 monthsClinicians participating in the study.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Clinicians Who Have Received Drug Addiction Treatment Act (DATA) of 2000 Training18 monthsClinicians participating in the study.ParticipantsCOUNT_OF_PARTICIPANTS

Results by group10

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual CareClinical Decision Support for BUP347Participants
Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual CareUsual Care271Participants
Count of Those With Referral to Follow-up for Ongoing MOUD Treatment (Patient Level)Clinical Decision Support for BUP367Participants
Count of Those With Referral to Follow-up for Ongoing MOUD Treatment (Patient Level)Usual Care226Participants
Number of Clinicians Providing ED-initiated BUPClinical Decision Support for BUP151Participants
Number of Clinicians Providing ED-initiated BUPUsual Care88Participants
Number of Clinicians Providing Referral of Any Ongoing MOUD TreatmentClinical Decision Support for BUP141Participants
Number of Clinicians Providing Referral of Any Ongoing MOUD TreatmentUsual Care100Participants
Number of Clinicians Who Have Received Drug Addiction Treatment Act (DATA) of 2000 TrainingClinical Decision Support for BUP50Participants
Number of Clinicians Who Have Received Drug Addiction Treatment Act (DATA) of 2000 TrainingUsual Care30Participants

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
PatientsSTARTEDClinical Decision Support for BUP2,787
PatientsSTARTEDUsual Care2,260
PatientsCOMPLETEDClinical Decision Support for BUP2,787
PatientsCOMPLETEDUsual Care2,260
PatientsNOT COMPLETEDClinical Decision Support for BUP0
PatientsNOT COMPLETEDUsual Care0
PhysiciansSTARTEDClinical Decision Support for BUP340
PhysiciansSTARTEDUsual Care259
PhysiciansCOMPLETEDClinical Decision Support for BUP340
PhysiciansCOMPLETEDUsual Care259

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityClinical Decision Support for BUP02,787
Total, all-cause mortalityUsual Care02,260
Total, other adverse eventsClinical Decision Support for BUP02,787
Total, other adverse eventsUsual Care02,260
Total, serious adverse eventsClinical Decision Support for BUP02,787
Total, serious adverse eventsUsual Care02,260

Papers5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
31152039DERIVEDPubMed
32309637DERIVEDPubMed
35760423DERIVEDPubMed
37948075DERIVEDPubMed
41287157DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
UG3DA047003EMBED: Pragmatic trial of user-centered clinical decision support to implement EMergency department-initiated BuprenorphinE for opioid use DisorderMELNICK, EDWARD ROBERT; D'ONOFRIO, GAILYALE UNIVERSITYNATIONAL INSTITUTE ON DRUG ABUSE2018

Trial comparisons7

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Clinical Decision Support for BUP vs Usual Care: Number of Clinicians Providing Referral of Any Ongoing MOUD TreatmentTrial comparisons
Clinical Decision Support for BUP vs Usual Care: Number of Clinicians Who Have Received Drug Addiction Treatment Act (DATA) of 2000 TrainingTrial comparisons
Clinical Decision Support for BUP vs Usual Care: Number of Clinicians Providing ED-initiated BUPTrial comparisons
Clinical Decision Support for BUP vs Usual Care: Count of Those With Referral to Follow-up for Ongoing MOUD Treatment (Patient Level)Trial comparisons
Clinical Decision Support for BUP vs Usual Care: Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual CareTrial comparisons
Clinical Decision Support for BUP vs Usual Care: deaths from any causeTrial comparisons
Clinical Decision Support for BUP vs Usual Care: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03658642

GET https://conductscience.org/api/trials/v1/NCT03658642/registered